Amgen (Germany) Today
| AMG Stock | EUR 252.85 1.45 0.57% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Amgen is selling for under 252.85 as of the 5th of January 2025; that is 0.57% down since the beginning of the trading day. The stock's last reported lowest price was 252.85. Amgen has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 10th of February 2024 and ending today, the 5th of January 2025. Click here to learn more.
Moving against Amgen Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Amgen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Amgen's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Amgen or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Heinz Schimmelbusch |
| Business Concentration | Other, Other (View all Sectors) |
Amgen Inc (AMG) is traded on Munich Exchange in Germany and employs 20 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 105.18 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Amgen's market, we take the total number of its shares issued and multiply it by Amgen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Amgen Inc operates under Other sector and is part of Other industry.
Amgen generates positive cash flow from operations, but has no cash available
Check Amgen Probability Of Bankruptcy
Amgen Inc Risk Profiles
Although Amgen's alpha and beta are two of the key measurements used to evaluate Amgen's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.9931 | |||
| Standard Deviation | 1.8 | |||
| Variance | 3.23 | |||
| Risk Adjusted Performance | (0.06) |
Amgen Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Amgen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Amgen Corporate Executives
Elected by the shareholders, the Amgen's board of directors comprises two types of representatives: Amgen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amgen. The board's role is to monitor Amgen's management team and ensure that shareholders' interests are well served. Amgen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amgen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jackson Dunckel | Member of the Management Board, Chief Financial Officer | Profile |
Additional Tools for Amgen Stock Analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.